# ยง 427.100   Definitions.

As used in this subpart, the following definitions apply:


*EUA Declaration* means the March 27, 2020, Emergency Use Authorization (EUA) Declaration for Drugs and Biological Products under section 564 of the Food, Drug, and Cosmetic (FD&C) Act.


*Individual who uses such a drug or biological* means a unique Medicare Part B beneficiary who was furnished the Part B drug or biological that was covered under Part B during the applicable calendar quarter, identified using final action claims data with dates of service during the calendar year set forth in ยง 427.101(b)(6) and with allowed charges greater than zero.






